Filing Details
- Accession Number:
- 0001209191-14-068520
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2014-11-13 16:06:03
- Reporting Period:
- 2014-11-12
- Filing Date:
- 2014-11-13
- Accepted Time:
- 2014-11-13 16:06:03
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1174940 | Oragenics Inc | OGEN | Pharmaceutical Preparations (2834) | 593410522 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1234877 | Beverly Koski | 3525 Turtle Creek Bouldevard, Unit 19-B Dallas TX 75219 | No | No | Yes | No | |
1234878 | L Christine Koski | 3525 Turtle Creek Bouldevard, Unit 19-B Dallas TX 75219 | Yes | No | Yes | No | |
1234879 | Koski Family Lp | 3525 Turtle Creek Boulevard, Unit 19-B Dallas TX 75219 | No | No | Yes | No | |
1234880 | C Robert Koski | 7362 Hawkins Road Sarasota FL 34241 | Yes | No | Yes | No | |
1234881 | L Thomas Koski | 4995 Ashley Parkway Sarasota FL 34241 | No | No | Yes | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2014-11-12 | 2,700 | $0.84 | 612,578 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2014-11-12 | 200 | $0.85 | 612,778 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2014-11-12 | 10,200 | $0.85 | 622,978 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2014-11-12 | 200 | $0.87 | 623,178 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2014-11-12 | 1,800 | $0.87 | 624,978 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 8,257,742 | Direct | |
Common Stock | 1,051,723 | Direct | |
Common Stock | 519,666 | Direct | |
Common Stock | 20,000 | Indirect | By Koski Management, Inc. |
Common Stock | 530,851 | Indirect | By Trusts |
Footnotes
- Shares owned directly by Koski Family Limited Partnership. Shares owned indirectly by Beverly Koski (through Koski Management, Inc. solely owned by Beverly Koski), Christine L. Koski, Robert C. Koski and Thomas L. Koski, each of whom is a general partner of the partnership or the controlling person of a corporate general partner of the partnership.
- Each reporting person disclaims beneficial ownership of all indirectly owned securities in excess of such reporting person's pecuniary interest therein, and this report shall not be deemed an admission that the reporting person is the beneficial owner for purposes of Section 16 or any other purpose.
- Shares owned directly by Christine L. Koski.
- Shares owned directly by Robert C. Koski.
- Shares owned directly by Thomas L. Koski.
- Shares owned indirectly by Beverly Koski (through Koski Management, Inc).
- Shares owned by trusts of which Mr. Robert C. Koski is sole trustee. Such trusts are as follows: the Robert Clayton Koski Trust for the benefit of Anthony James Hunter (100,000 shares); the Robert Clayton Koski Trust for the benefit of Hunter Buchanan Koski (100,000 shares); the Robert Clayton Koski Trust for the benefit of Clayton Ward Bennett (100,000 shares); the Robert Clayton Koski Trust for the benefit of Robert Edward Koski (100,000 shares); and the Robert Clayton Koski Trust for the benefit of Elyse Margaux Koski (97,666 shares). Mr. Koski disclaims beneficial ownership of the shares held by the trusts except to the extent of any pecuniary interest.